Vocal biomarkers enable diagnosis, monitoring capabilities :

Vocal biomarkers enable diagnosis, monitoring capabilities


A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions.
OSP: Could you please share the ‘elevator presentation’ description of Vocalis—who you are, what you do, and what sets you apart?​
SH: Vocalis Health is an AI health tech company pioneering the development of vocal biomarkers – where health-related information is derived from analysis of people’s voice recordings – to screen, detect, monitor and predict health symptoms, conditions and diseases. 
In 2016, I co-founded Vocalis Health with Daniel Aronovich, chief technical officer of the company. While treating patients in the hospital, I realized that I was habitually listening to their voices to gauge the state of their health.

Related Keywords

Daniel Aronovich , Vocalis Health , Shady Hassan , Clinical Development , Covid 19 , Patient Centricity , Clinical Evolution , Analytical Testing , Hqc , Phasei Ii , Phase Iii Iv , Biomarkers , Testing , Patient Outcomes , Corona Virus , டேனியல் ஆரோனோவிச் , நிழலான ஹாசன் , மருத்துவ வளர்ச்சி , மருத்துவ பரிணாமம் , பகுப்பாய்வு சோதனை , க்ஸீ , கட்டம் ஈயீ இவ் , பயோமார்க்ஸ் , சோதனை , நோயாளி ஔட்கம்ஸ் , கொரோனா வைரஸ் ,

© 2025 Vimarsana